Skip to content

APOTHEEK PLATTEEUW B

Active
Private limited companyfounded 200223 yrs activeElzelestraat 102, 9600 Ronse, BelgiumKBO/BCE: BE 0478.986.889

APOTHEEK PLATTEEUW B has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €613k and a net result of €137k. Equity is growing by ~5.3% per year across the filed fiscal years. Its solvency ranks better than 60% of 10331 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).

Checked score

Score 2025
74 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability82▲+18
Solvency71=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45k at 30 days acceptable
Liquidity ample (current ratio 2.28 against 2.09 in 2024; short-term debt: 20.3% and cash: 10% of total assets), but 53.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 23 years 0 30 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
46.3%
Return on assets
10.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
14 d early
2024
36 d early
2023
65 d early
2022
238 d late
2021
39 d early
2020
44 d early
2019
49 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€613k▼ 0.7%
2024 · €618k
2018: €380k 2019: €464k 2020: €577k 2021: €623k 2022: €691k 2023: €600k 2024: €618k
2018 → 2025
Total assets
€1.32M▼ 1.4%
2024 · €1.34M
2018: €819k 2019: €836k 2020: €863k 2021: €963k 2022: €1.01M 2023: €1.44M 2024: €1.34M
2018 → 2025
Net result
€137k▲ 38.2%
2024 · €99k
2018: €79k 2019: €89k 2020: €117k 2021: €91k 2022: €113k 2023: €115k 2024: €99k
2018 → 2025
Working capital
€345k▲ 6.8%
2024 · €323k
2018: €371k 2019: €462k 2020: €553k 2021: €461k 2022: €522k 2023: €410k 2024: €323k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€623k-€691k▲ 11.0%€600k▼ 13.2%€618k▲ 3.0%€613k▼ 0.7%
Operating result€64k-€93k▲ 47.0%€98k▲ 5.1%€99k▲ 1.2%€131k▲ 31.6%
Net result€91k-€113k▲ 24.2%€115k▲ 1.7%€99k▼ 13.2%€137k▲ 38.2%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2021: €64k€64kNet result 2021: €91k€91kOperating result 2022: €93k€93kNet result 2022: €113k€113kOperating result 2023: €98k€98kNet result 2023: €115k€115kOperating result 2024: €99k€99kNet result 2024: €99k€99kOperating result 2025: €131k€131kNet result 2025: €137k€137k20212022202320242025
The operating result has risen four years in a row; 2025 is 32% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.32M
Fixed assets €711k▼ 1.7%
Current assets €613k▼ 1.1%
Equity and liabilities €1.32M
Equity €613k▼ 0.7%
Debt €712k▼ 2.0%
The debt ratio falls from 54.1% to 53.7%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€194k
2024 · €154k
Cash flow
€201k
2024 · €154k
Solvency
46.3%
2024 · 45.9%
Current ratio
2.28
2024 · 2.09
Quick ratio
1.01
2024 · 1.08
Debt / equity
1.16
2024 · 1.18
ROE
22.4%
2024 · 16.1%
ROA
10.4%
2024 · 7.4%
Interest coverage
7.04
2024 · 4.36
Debt
€712k
2024 · €726k
Debt ≤ 1 year
€269k
2024 · €297k
Debt > 1 year
€392k
2024 · €416k
Income taxes
€37k
2024 · €39k
Staff costs
€146k
2024 · €177k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.34M€1.32M
Fixed assets21/28€724k€711k
Tangible fixed assets22/27€719k€706k
Land and buildings22€649k€624k
Plant, machinery and equipment23€9k€7k
Furniture and vehicles24€60k€75k
Financial fixed assets28€5k€5k=
Current assets29/58€620k€613k
Stocks and contracts in progress3€300k€341k
Stocks30/36€300k€341k
Amounts receivable within one year40/41€111k€6k
Trade receivables40€111k€6k
Other amounts receivable41€2€2=
Cash at bank and in hand54/58€203k€132k
Deferred charges and accrued income490/1€6k€134k
Equity and liabilities
Total equity and liabilities10/49€1.34M€1.32M
Equity10/15€618k€613k
Contributions10/11€12k€12k=
Reserves13€605k€601k
Distributable reserves133€605k€601k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€726k€712k
Amounts payable after more than one year17€416k€392k
Financial debts170/4€416k€392k
Amounts payable within one year42/48€297k€269k
Current portion of amounts payable after more than one year42€53k€64k
Financial debts43€10k€10k=
Credit institutions430/8€10k€10k=
Trade debts44€53k€27k
Suppliers440/4€53k€27k
Taxes, remuneration and social security45€42k€35k
Taxes450/3€7k€7k
Remuneration and social security454/9€35k€28k
Other amounts payable47/48€139k€132k
Accrued charges and deferred income492/3€13k€51k
Income statement Code20242025
Remuneration, social security and pensions62€177k€146k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€55k€63k
Other operating charges640/8€8k€7k
Gross operating margin9900€338k€348k
Operating profit (loss)9901€99k€131k
Financial income75/76B€74k€71k
Recurring financial income75€74k€71k
Financial charges65/66B€35k€28k
Recurring financial charges65€35k€28k
Profit (loss) for the period before taxes9903€138k€175k
Income taxes67/77€39k€37k
Profit (loss) for the period9904€99k€137k
Profit (loss) for the period to be appropriated9905€99k€137k
Appropriation of the result
Profit (loss) to be appropriated9906€99k€137k
Transfer from equity791/2€74k€134k
Transfer to equity691/2€92k€130k
To other reserves6921€92k€130k
Profit to be distributed694/7€82k€142k
Return on contributions (dividend)694€74k€134k
Other beneficiaries697€7k€8k
Social balance
Average headcount (FTE)90872.62.0

The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
17-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial Highest result since 2018net €137k ▲38.2%
Operating result €131k, net result €137k, both a record.
25-06
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
27-05
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
25-03
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 238 days late
2022
22-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
17-06
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial Equity above €500kEq €577k ▲24.2%
3 profitable years in a row build equity to €577k.
12-06
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
12-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
19-06
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
04-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ronse · 1 establishment unit since 2002
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Elzelestraat 1029600 Ronse
Ground area
374 m²
Building footprint
246 m²
Volume, LiDAR
1,614 m³
Parcel 45422C0053/00M003, Flanders · tallest building 13.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK PLATTEEUW B.
Elzelestraat 102, 9600 RonseWarehousing and support activities for transportation
since 20022.114.772.917
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
45422C0053/00M003 Flanders 374 m² 1 · 246 m² 13.6 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2023 to 2024 · 2 entries · 169 EUR awarded · 124 EUR paid
Year Entries awardedpaid
2024 1 45 EUR0 EUR
2023 1 124 EUR124 EUR
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
2 entries · 169 EUR · 124 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,284 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded13-12-2002
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 23 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.